Jenny Kobin | Investor Relations |
George Lasezkay | President and Chief Executive Officer |
Charles Deignan | Chief Financial Officer |
Annabel Samimy | Stifel |
Serge Belanger | Needham & Company |
Jonathan Wolleben | JMP Securities |
Yi Chen | H.C. Wainwright |
Good day and thank you for standing by and welcome to the Clearside Biomedical Fourth Quarter 2022 Financial Results and Corporate Update Conference Call. At this time all participants are in a listen-only mode. After the speakers' presentation there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your speaker today, Jenny Kobin, Investor Relations.